Customer Service 1 (888) 261-2693
Please enter Search keyword. Advanced Search
Home About Us Resources Archive Free Reports Market Window

This Indicator Will Warn You Before Stocks Fall

By Tom Dyson, publisher, The Palm Beach Letter
Monday, September 21, 2009

In December 2005, Citigroup announced a new 10-year, $100 million bond issue...

At any time, Citigroup has hundreds of different bond issues trading in the markets. Right now, for example, my Bloomberg terminal shows over 500 different Citigroup bonds. There was nothing special about this 2005 issue...

The housing market was rising, Wall Street's mortgage machine was in full swing, and America was enjoying the peak of its prosperity. At the time, you and I were paying 6% to borrow money secured against our houses. Citigroup would pay 5.3% to borrow money, unsecured.

For two years, these bonds traded in a narrow band between $95 and $105. Then in March 2008, Bear Stearns failed and prices started to erode...

Citi's bonds broke $90 in July, when Fannie Mae and Freddie Mac failed. They broke $80 in September, when Lehman failed. And by March 2009, when it seemed Citigroup itself might fail, they had fallen to $62...

Here's the thing: In the last six months, the credit markets have made a remarkable recovery. This bombed-out Citigroup bond issue now trades for $99 again. In other words, investors are pricing these bonds as if the credit crisis never happened. Amazing.

This chart of the investment-grade bond fund LQD is even more amazing. It shows prices of top-quality corporate bonds have surged and are now back to 2006 levels...

Corporate Bonds Are Nearing Credit-Bubble Highs
Complacency returns: the VIX and its downtrend

Most people don't know this, but the bond market is far more important to America's economy than the stock market. For one thing, the bond market is over five times as large as the stock market. For another thing, institutions dominate the bond market. They may not be the shrewdest investors in the world, but they are sophisticated, they trade billions, and they trade with less emotion. The stock market is a roadside casino in comparison, reflecting the hopes and dreams of a million gamblers.

I don't recommend you buy LQD or corporate bonds in general. They're expensive now. Besides, government support is the only reason the bond market is soaring and Citigroup's bonds are trading back at par. If the government withdraws this support for some reason, the bond market will collapse again.

Instead, use the bond market as an indicator. Russell Napier, a well-known stock market historian, studied market tops and bottoms over the last 100 years and showed corporate bonds tend to lead the stock market by several months at important turning points.

Today, the trend is clearly up. So for now, stock market investors have nothing to worry about. But keep an eye on LQD. It should give us advance warning of the next trend change in the stock market.

Good investing,

Tom




Market Notes


NEW HIGHS OF NOTE LAST WEEK

Goldcorp (GG)... giant gold miner
Sterlite (STL)... giant copper miner
Cameco (CCJ)... giant uranium miner
BHP Billiton (BHP)... giant everything miner
Gold Fields (GFI)... gold mining
Agnico-Eagle (AEM)... gold mining
Kinross Gold (KGC)... gold mining
AngloGold Ashanti (AU)... gold mining
Silver Wheaton (SLW)... silver royalties
Cresud (CRESY)... Argentine farmland
Google (GOOG)... search engine
Baidu (BIDU)... the Google of China
EBay (EBAY)... online auctions
Apple (AAPL)... iPods and computers
P.F. Chang's (PFCB)... restaurants
Polo Ralph Lauren (RL)... fine clothing
Bed Bath & Beyond (BBBY)... home furnishing
Starbucks (SBUX)... deficit coffee spending
Annaly Capital (NLY)... virtual bank
Hatteras Financial (HTS)... virtual bank
Capstead Mortgage (CMO)... virtual bank
Goldman Sachs (GS)... virtual control of the U.S. Treasury


NEW LOWS OF NOTE LAST WEEK

U.S. dollar... again.

In The Daily Crux



Recent Articles
Legal Notices: Stansberry Research LLC (Stansberry Research) is a publishing company and the indicators, strategies, reports, articles and all other features of our products are provided for informational and educational purposes only and should not be construed as personalized investment advice. Our recommendations and analysis are based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.

 

Readers should be aware that trading stocks and all other financial instruments involves risk. Past performance is no guarantee of future results, and we make no representation that any customer will or is likely to achieve similar results.

 

Our testimonials are the words of real subscribers received in real letters, emails, and other feedback who have not been paid for their testimonials. Testimonials are printed under aliases to protect privacy, and edited for length. Their claims have not been independently verified or audited for accuracy. We do not know how much money was risked, what portion of their total portfolio was allocated, or how long they owned the security. We do not claim that the results experienced by such subscribers are typical and you will likely have different results.

 

Any performance results of our recommendations prepared by Stansberry Research are not based on actual trading of securities but are instead based on a hypothetical trading account. Hypothetical performance results have many inherent limitations. Your actual results may vary.

 

Stansberry Research expressly forbids its writers from having a financial interest in any security they recommend to our subscribers. And all Stansberry Research (and affiliated companies), employees, and agents must wait 24 hours after an initial trade recommendation is published on the Internet, or 72 hours after a direct mail publication is sent, before acting on that recommendation.

 

© 2024 Stansberry Research, LLC. | Privacy Policy| Customer Service
Stansberry Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This website may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry Research, LLC. 1125 N Charles St. Suite 500, Baltimore MD 21202.